KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $2.7 billion.

  • Edwards Lifesciences' Cash & Equivalents fell 2695.03% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year decrease of 2695.03%. This contributed to the annual value of $3.0 billion for FY2024, which is 16893.93% up from last year.
  • Per Edwards Lifesciences' latest filing, its Cash & Equivalents stood at $2.7 billion for Q3 2025, which was down 2695.03% from $3.3 billion recorded in Q2 2025.
  • Edwards Lifesciences' Cash & Equivalents' 5-year high stood at $3.7 billion during Q3 2024, with a 5-year trough of $761.5 million in Q4 2022.
  • For the 5-year period, Edwards Lifesciences' Cash & Equivalents averaged around $1.7 billion, with its median value being $1.2 billion (2022).
  • In the last 5 years, Edwards Lifesciences' Cash & Equivalents plummeted by 2707.91% in 2021 and then skyrocketed by 16893.93% in 2024.
  • Over the past 5 years, Edwards Lifesciences' Cash & Equivalents (Quarter) stood at $862.8 million in 2021, then dropped by 11.74% to $761.5 million in 2022, then soared by 48.69% to $1.1 billion in 2023, then surged by 168.94% to $3.0 billion in 2024, then dropped by 11.81% to $2.7 billion in 2025.
  • Its last three reported values are $2.7 billion in Q3 2025, $3.3 billion for Q2 2025, and $3.1 billion during Q1 2025.